Non-recent history of influenza pandemics, vaccines, and adjuvants

  • Maria Lattanzi
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)


Mankind has been affected by influenza epidemics and pandemics for many centuries. As for many others infectious diseases, measures to reduce the heavy burden of this disease through prevention were first developed during the 20th century. The purpose of this chapter is to describe the non-recent history of influenza, including the origin of the disease, the pandemics and the epidemics. Moreover, we also discuss the first attempts to develop safe and efficacious vaccines, including the negative experience with the swine influenza vaccination and the numerous attempts to improve the efficacy of influenza vaccines using adjuvants carried out since the 1950s.


Influenza Vaccine Influenza Pandemic VACC INATION Swine Influenza Influenza Virus Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ghendon Y (1994) Introduction to pandemic influenza through history. Eur J Epidemiol 10: 451–453PubMedCrossRefGoogle Scholar
  2. 3.
    Fukuda K, Levandowski RA, Bridges CB, Cox NJ (2004) Inactivated influenza vaccines. In: SA Plotkin, WA Orenstein (eds): Vaccines, 4th edn. Saunders, Philadelphia, 339–370Google Scholar
  3. 4.
    Potter CW (1998) Chronicle of influenza pandemics. In: KG Nicholson, RF Webster, AJ Hay (eds): Textbook of Influenza. Blackwell Science, Oxford, 3–18Google Scholar
  4. 5.
    Hirsch A (1883) Handbook of Geographical and Historical Pathology. New Sydenham Society, LondonGoogle Scholar
  5. 6.
    Pyle GF (1986) The Diffusion of Influenza: Patterns and Paradigms. Rowan & Littlefield, New JerseyGoogle Scholar
  6. 7.
    Beveridge WIB (1991) The chronicle of influenza epidemics. History Philos Life Sci 13: 223–235Google Scholar
  7. 8.
    Potter CW (2001) A history of influenza. J Appl Microbiol 91: 572–579PubMedCrossRefGoogle Scholar
  8. 9.
    Finkler D (1899) Influenza in twentieth century practice. In: TL Shipman (ed): An International Encyclopaedia of Modern Medical Science. Sampson Law & Marston, London, abstract 12, 21–32Google Scholar
  9. 10.
    Patterson KD (1987) Pandemic Influenza 1700-1900; A Study in Historical Epidemiology. Rowman & Littlefield, New JerseyGoogle Scholar
  10. 11.
    Brown MW (1932) Early epidemics of influenza in America. J Med Rec 135: 449–451Google Scholar
  11. 12.
    Beveridge WIB (1977) Influenza: The Last Great Plague. Heinemann, LondonGoogle Scholar
  12. 13.
    Pyle GF, Patterson K (1984) Influenza diffusion in European history: Patterns and paradigms. Ecol Dis 2: 173–184Google Scholar
  13. 14.
    Thompson ES (1890) Influenza. Pervical, LondonGoogle Scholar
  14. 15.
    Burnet FM, Clark E (1942) Influenza. A survey of the last 50 years in the light of modern work on the virus of epidemic influenza. Monogr Walter Eliza Hall Inst Res Pathol Med 69–99Google Scholar
  15. 16.
    Shope RE (1931) Swine influenza: Experimental transmission and pathology. J Exp Med 54: 349–359CrossRefGoogle Scholar
  16. 17.
    Hope-Simpson R (1978) Sunspots and flu: A correlation. Nature 275: 86CrossRefGoogle Scholar
  17. 18.
    Francis T Jr, Magill TP (1937) The antibody response of human subjects vaccinated with the virus of human influenza. J Exp Med 65: 251–259CrossRefGoogle Scholar
  18. 19.
    Francis T Jr (1945) The development of the 1943 vaccination study of the commission on influenza. Am J Hygiene 42: 1–11Google Scholar
  19. 20.
    Francis T Jr, Salk JE, Pearson HE, Brown PN (1945) Protective effect of vaccination against induced influenza A. J Clin Invest 24: 536–546PubMedCrossRefGoogle Scholar
  20. 21.
    Salk JE, Menke WJ, Francis T Jr (1945) A clinical, epidemiological and immunological evaluation of vaccination against epidemic influenza. Am J Hyg 42: 57–93Google Scholar
  21. 22.
    Gregg MB (1974) Recent advances in influenza vaccines. J Med 16: 651–653Google Scholar
  22. 23.
    Cate TR, Couch RB, Parker D, Baxter B (1983) Ractogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978. Rev Infect Dis 5: 737–747PubMedGoogle Scholar
  23. 24.
    Spila-Alegiani S, Salmaso S, Rota MC, Tozzi A, Raschetti R, the Italian SVEVA group (1999) Reactogenicity in the elderly of nine commercial influenza vaccines: Results from the Italian SVEVA study. Vaccine 17: 1898–1904PubMedCrossRefGoogle Scholar
  24. 25.
    Kendal AP, Goldfield M, Noble GR, Dowdle WR (1977) Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis 136 (Suppl): S381–S385PubMedGoogle Scholar
  25. 26.
    Goldfield M, Bartley JD, Pizzuti W, Black HC, Altman R, Halperin WE (1977) Influenza in New Jersey in 1976: Isolation of influenza A/New Jersey/76 virus at Fort Dix. J Infect Dis 136 (Suppl): S347–S355PubMedGoogle Scholar
  26. 27.
    Top FH, Russell PK (1977) Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis 136 (Suppl): S376–S380PubMedGoogle Scholar
  27. 28.
    Gaydos JC, Top FH, Hodder RA, Russer PK (2006) Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 12: 23–28PubMedGoogle Scholar
  28. 29.
    Langmuir AD (1979) Guillain-Barrè syndrome: The swine influenza virus vaccine incident in the United States of America, 1976-1977; preliminary communication. J R Soc Med 72: 660–669PubMedGoogle Scholar
  29. 30.
    Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA (1979) Guillain-Barrè syndrome following vaccination in the national influenza immunization program, United States, 1976–1977. Am J Epidemiol 110: 105–123PubMedGoogle Scholar
  30. 31.
    Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M (1984) An epidemiologic and clinical evaluation of Guillain-Barrè syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 119: 841–879PubMedGoogle Scholar
  31. 32.
    Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT (1998) The Guillain-Barrè syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 339: 1797–1802PubMedCrossRefGoogle Scholar
  32. 33.
    Haber P, De Stefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT (2004) Guillain-Barrè syndrome following influenza vaccination. JAMA 292: 2478–81PubMedCrossRefGoogle Scholar
  33. 34.
    Salk JE (1953) Use of adjuvants in studies on influenza immunization. 3. Degree of persistence of antibody in human subjects two years after vaccination. JAMA 151: 1169–1175Google Scholar
  34. 35.
    Salk JE, Bailey ML, Laurel AM (1952) The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water-in-oil emulsion. Am J Hyg 55: 439–456PubMedGoogle Scholar
  35. 36.
    Davenport FM (1968) Seventeen years’ experience with mineral oil adjuvant influenza virus vaccines. Ann Allergy 26: 288–292PubMedGoogle Scholar
  36. 37.
    Beebe GW, Simon AH, Vivona S (1964) Follow-up study on Army personnel who received adjuvant influenza virus vaccine 1951-1953. Am J Med Sci 247: 385–405PubMedCrossRefGoogle Scholar
  37. 38.
    Beebe GW, Simon AH, Vivona S (1972) Long-term mortality follow-up of Army recruits who received adjuvant influenza virus vaccine in 1951-1953. Am J Epidemiol 95: 337–346PubMedGoogle Scholar
  38. 39.
    Hennessy AV, Davenport FM (1961) Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule. Public Health Rep 76: 411–419PubMedGoogle Scholar
  39. 40.
    Davenport FM, Hennessy AV, Bell JA (1962) Immunologic advantages of emulsified influenza virus vaccines. Mil Med 127: 95–100PubMedGoogle Scholar
  40. 41.
    Davis DJ, Philip RN, Bell JA, Voegel JE, Jensen DV (1961) Epidemiological studies on influenza in familiar and general population groups. 1951-1956. III. Laboratory observations. Am J Hyg 73: 138–147PubMedGoogle Scholar
  41. 42.
    Stuart-Harris CH (1967) Scientific Publication No. 147, PAIIO, 573Google Scholar
  42. 43.
    Davenport FM (1968) Antigenic enhancement of ether-extracted influenza virus vaccines by AIPO4. Proc Soc Exp Biol Med 127: 587–590PubMedGoogle Scholar
  43. 44.
    Davenport FM, Hennessy AV, Askin FB (1968) Lack of adjuvant effect of AlPO4 on purified influenza virus hemagglutinins in man. J Immunol 100: 1139–1140PubMedGoogle Scholar
  44. 45.
    Werner J, Kuwert EK, Stegmaier R, Simbock H (1980) [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. II. Neuraminidase inhibiting antibodies (author’s transl)]. Zentralbl Bakteriol A 246: 1–9PubMedGoogle Scholar
  45. 46.
    D’Errico MM, Grasso GM, Romano F, Montanaro D (1988) [Comparison of anti-influenza vaccines: Whole adsorbed trivalent, trivalent subunit and tetravalent subunit]. Boll Ist Sieroter Milan 67: 283–289PubMedGoogle Scholar
  46. 47.
    Ionita E, Lupulescu E, Alexandrescu V, Matepiuc M, Constantinescu C, Cretescu L et al (1989) Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I. Arch Roum Pathol Exp Microbiol 48: 265–273PubMedGoogle Scholar
  47. 48.
    Van Nest GA, Steimer KS, Haigwood NL, Burke RL, Ott G (1992) Advanced adjuvant formulations for use with recombinant subunit vaccines. In: F Brown, RM Chanock, HS Ginsberg, RA Lerner (eds): Vaccines 92. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 57–62Google Scholar
  48. 49.
    Baylor NW, Egan W, Richman P (2002) Aluminum salts in vaccines-US perspective. Vaccine 20: S18–S23PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2008

Authors and Affiliations

  • Maria Lattanzi
    • 1
  1. 1.Novartis Vaccines and DiagnosticsSienaItaly

Personalised recommendations